Biogen Inc

NASDAQ: BIIB
Share price (4/29/24): $215.50
Market cap (4/29/24): $31.4 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

8 Biogen Inc Expert Interviews, now on BamSEC.

Powered by Tegus.

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 87 pages Agreement and Plan of Merger by and Among Reata Pharmaceuticals, Inc., Biogen Inc. and River Acquisition, Inc. Dated as of July 28, 2023

from 8-K 83 pages Separation Agreement by and Between Biogen Inc. and Bioverativ Inc. Dated as of January 31, 2017

from 8-K/A 98 pages Asset Purchase Agreement by and Among Elan Pharma International Limited, Elan Pharmaceuticals, Inc. and Biogen Idec International Holding Ltd. Dated as of February 5, 2013

from 8-K ~50 pages Agreement and Plan of Merger by and Among Idec Pharmaceuticals Corporation, Bridges Merger Corporation and Biogen, Inc. Dated as of June 20, 2003

from 8-A12B ~50 pages Rights Agreement

from 8-B12G ~10 pages Agreement and Plan of Merger